Your comment about Peter Griffiths being interested in the data is dead on. Take a look at this youtube interview with Dr. Adrian Attard Trevisan, Neurotech's founder and Chief Scientific Officer:
.
AAT Research is a subsidiary of Neurotech International. Mente is their first flagship product but they will branch out into different areas given time. Take a look at this line from the 'About Us' page on Neurotech's website: "Neurotech and the Mente technology sit at the confluence of several market forces, including a heightened focus on understanding the brain, the increasing diagnosis of neurological conditions and the increasing adoption of home-based precision healthcare."
This would include neuromarketing (Which is written on the wall behind Dr. Trevisan in the youtube video). It's easy to see why Peter Griffiths is interested. I expect big things from this company. Just picked up some share today.
